Compare Charlie Hospital Semarang Tbk. (RSCH) vs Zyrexindo Mandiri Buana Tbk. (ZYRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charlie Hospital Semarang Tbk. vs Zyrexindo Mandiri Buana Tbk. — how do they compare? Charlie Hospital Semarang Tbk. trades at Rp270 (market cap 742B, 29.45M 24h volume), while Zyrexindo Mandiri Buana Tbk. trades at Rp129 (market cap 173.33B, 1.04M 24h volume). The key difference: Charlie Hospital Semarang Tbk. is far larger — about 4.3× Zyrexindo Mandiri Buana Tbk.'s market cap, and Charlie Hospital Semarang Tbk. is more actively traded (29.45M versus 1.04M). Which is the better fit depends on your goals.
| RSCH | ZYRX | |
|---|---|---|
Market Cap | 742B | 173.33B |
Volume | 29.45M | 1.04M |
Lot | 294.49K | 10.41K |
Turnover | 8.14B | 134.49M |
Average Price | 276.35 | 129.19 |
Value | 8.14B | 134.49M |
Indicative Equilibrium Price | 270 | 129 |
Indicative Equilibrium Volume | 103 | 15 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Charlie Hospital Semarang Tbk.
PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →About Zyrexindo Mandiri Buana Tbk.
PT Zyrexindo Mandiri Buana Tbk (the Company) is a limited liability company established in Indonesia based on Notarial Deed No. 43 of Jimmy Simanungkalit, S.H., on May 14, 1996. The Company commenced its commercial operations in 1996. The majority shareholder of the Company is Timothy Siddik
Read more on ZYRX →
